Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;301(3):F529-35.
doi: 10.1152/ajprenal.00596.2010. Epub 2011 Jan 26.

Aldosterone stimulates superoxide production in macula densa cells

Affiliations

Aldosterone stimulates superoxide production in macula densa cells

Xiaolong Zhu et al. Am J Physiol Renal Physiol. 2011 Sep.

Abstract

Two major factors which regulate tubuloglomerular feedback (TGF)-mediated constriction of the afferent arteriole are release of superoxide (O(2)(-)) and nitric oxide (NO) by macula densa (MD) cells. MD O(2)(-) inactivates NO; however, among the factors that increase MD O(2)(-) release, the role of aldosterone is unclear. We hypothesize that aldosterone activates the mineralocorticoid receptor (MR) on MD cells, resulting in increased O(2)(-) production due to upregulation of cyclooxygenase-1 (COX-2) and NOX-2, and NOX-4, isoforms of NAD(P)H oxidase. Studies were performed on MMDD1 cells, a renal epithelial cell line with properties of MD cells. RT-PCR and Western blotting confirmed the expression of MR. Aldosterone (10(-8) mol/l for 30 min) doubled MMDD1 cell O(2)(-) production, and this was completely blocked by MR inhibition with 10(-5) mol/l eplerenone. RT-PCR, real-time PCR, and Western blotting demonstrated aldosterone-induced increases in COX-2, NOX-2, and NOX-4 expression. Inhibition of COX-2 (NS398), NADPH oxidase (apocynin), or a combination blocked aldosterone-induced O(2)(-) production to the same degree. These data suggest that aldosterone-stimulated MD O(2)(-) production is mediated by COX-2 and NADPH oxidase. Next, COX-2 small-interfering RNA (siRNA) specifically decreased COX-2 mRNA without affecting NOX-2 or NOX-4 mRNAs. In the presence of the COX-2 siRNA, the aldosterone-induced increases in COX-2, NOX-2, and NOX-4 mRNAs and O(2)(-) production were completely blocked, suggesting that COX-2 causes increased expression of NOX-2 and NOX-4. In conclusion 1) MD cells express MR; 2) aldosterone increases O(2)(-) production by activating MR; and 3) aldosterone stimulates COX-2, which further activates NOX-2 and NOX-4 and generates O(2)(-). The resulting balance between O(2)(-) and NO in the MD is important in modulating TGF.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Expression of mineralocorticoid receptor (MR) in MMDD1 cells. A: RT-PCR shows that the MMDD1 cells express the mRNA for the MR. Mouse myocytes were used as a positive control. B: Western blotting demonstrates the MR protein in MMDD1 cells.
Fig. 2.
Fig. 2.
Aldosterone (aldo) stimulates superoxide production via MR in MMDD1 cells. Aldosterone stimulates O2 significantly (n = 45, where n is the number of independent samples). Blocking MR with eplerenone (n = 45) blocked aldosterone-induced increased in O2. Eplerenone (n = 48) had no effect on O2 in the absence of aldosterone compared with control group (n = 44). *P < 0.05 vs. untreated cells, which were used as a control.
Fig. 3.
Fig. 3.
mRNAs of cyclooxygenase-2 (COX-2) and NOX-2 and NOX-4, isoforms of NAD(P)H oxidase, are detected in MMDD1 cells. RT-PCR shows that COX-2, NOX-2, and NOX-4 are expressed in MMDD1 cells. The ladder was cut from the same gel film.
Fig. 4.
Fig. 4.
Dose-response of aldosterone in mRNAs of COX-2, NOX-2, and NOX-4. Aldosterone at 10−9 and 10−8 mol/l for 30 min enhances mRNAs of COX-2, NOX-2, and NOX-4, and aldosterone at 10−8 mol/l had the greater effect; n = 3 for each group. *P < 0.05 vs. control.
Fig. 5.
Fig. 5.
Aldosterone enhances protein levels of COX-2, NOX-2, and NOX-4 as measured by Western blotting. Aldosterone at 10−8 mol/l for 30 min increases protein levels of COX-2, NOX-2, and NOX-4 in MMDD1 cells. The amount of protein for the band was 40 ng. The bands were cut from the same gel films. GAPDH was used as a control for both NOX-2 and NOX-4.
Fig. 6.
Fig. 6.
Aldosterone-induced O2 production is blocked by COX-2 or NAD(P)H oxidase inhibition. Aldosterone (10−8 mol/l) stimulated O2 significantly in MMDDl cells (n = 61) compared with untreated control cells (n = 58). Blocking COX-2 with NS-398 (n = 60), NAD(P)H oxidase with apocynin (n = 61), or both COX-2 and NAD(P)H oxidase (n = 48) blocked aldosterone-induced O2. *P < 0.05 vs. control. #P < 0.05 vs. aldosterone group.
Fig. 7.
Fig. 7.
Efficiency and specificity of COX-2 siRNA. A: effects of COX-2 small-interfering RNA (siRNA) or scrambled siRNA on COX-2 mRNA. COX-2 siRNA reduces COX-2 mRNA level significantly (n = 17) compared with the untreated control cells (n = 21). Scrambled siRNA (n = 6) had no effect on COX-2 mRNA level. B: knocking down COX-2 mRNA with COX-2 siRNA did not affect the NOX-2 and NOX-4 mRNAs (no. of experiments for each group: control = 9, NOX-2 = 9, NOX-4 = 12; COX-2 siRNA = 12, NOX-2 = 12, NOX-4 = 12). Scrambled siRNA (NOX-2 = 6, NOX-4 = 5) had no effect. *P < 0.05 vs. control.
Fig. 8.
Fig. 8.
COX-2 siRNA blocked aldosterone-induced increases in mRNAs of COX-2, NOX-2, and NOX-4. Aldosterone stimulated COX-2, NOX-2, and NOX-4 mRNA levels significantly (control = 7, COX-2 = 7, NOX-2 = 5, NOX-4 = 6; aldo+COX-2 = 5, aldo+NOX-2 = 5, aldo+NOX-4 = 4). Knocking down the COX-2 mRNA with COX-2 siRNA (COX-2 = 8, NOX-2 = 7, NOX-4 = 7) blocked the effect of aldosterone on COX-2, NOX-2, and NOX-4 mRNAs. *P < 0.05 vs. control.
Fig. 9.
Fig. 9.
COX-2 siRNA blocked aldosterone-induced increases in O2. Knocking down COX-2 mRNA with COX-2 siRNA blocked the effect of aldosterone on O2; n = 3. *P < 0.05 vs. untreated control cells.

Similar articles

Cited by

References

    1. Araujo M, Welch WJ. Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide. Am J Physiol Renal Physiol 296: F790–F794, 2009 - PMC - PubMed
    1. Arima S, Kohagura K, Xu HL, Sugawara A, Abe T, Satoh F, Takeuchi K, Ito S. Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol 14: 2255–2263, 2003 - PubMed
    1. Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38: 1107–1111, 2001 - PubMed
    1. Blantz RC, Pelayo JC. A functional role for the tubuloglomerular feedback mechanism. Kidney Int 25: 739–746, 1984 - PubMed
    1. DeMarco VG, Habibi J, Whaley-Connell AT, Schneider RI, Heller RL, Bosanquet JP, Hayden MR, Delcour K, Cooper SA, Andresen BT, Sowers JR, Dellsperger KC. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat. Am J Physiol Heart Circ Physiol 294: H2659–H2668, 2008 - PubMed

Publication types

MeSH terms

LinkOut - more resources